HRS Guidelines Bundle (free trial)

Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders

Heart Rhythm Society GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1499527

Contents of this Issue

Navigation

Page 38 of 49

39 Management strategies Key points • The consensus from neurology, general cardiology, and pulmonary medicine was that the patient is currently stable with reasonable prognosis at least for the next several years. • A discussion with the patient and his accompanying father was held to review the risks and benefits of a primary prevention ICD in FA. The risk of sudden cardiac death was discussed and shared decision making was carried out to elicit the medical care goals. • Options discussed included ongoing heart failure therapy with or without ICD placement. • Values elicited included the patient's desire for protection against sudden death in light of young age and satisfactory functional capacity. • The patient and family elected to proceed with a single-chamber ICD. • The procedure was performed without complications. The postprocedural hospital stay was prolonged due to slow recovery, with eventual return to baseline functioning after a 10-day acute rehabilitation stay. • Two years following ICD placement, the patient was doing well. The patient was no longer employed due to difficulty with transportation. No ICD therapies for VAs occurred since implantation. ICD interrogation revealed episodes of irregular tachycardia in a monitoring zone consistent with asymptomatic AF. A 14-day event monitor showed AF episodes lasting up to 24 hours with rates of 80–160 bpm. The patient was placed on anticoagulation, and the beta-blocker dosage was increased. • Progressive loss of muscle function with wheelchair dependence 10–20 years after symptom onset is common. • Concentric hypertrophy is often observed. It does not increase the risk of sudden death as in other genetic causes of HCM. • About 10% of patients develop left ventricular systolic dysfunction. The role of GDMT in limiting the progression of left ventricular systolic dysfunction has not been studied but is extrapolated from other populations. • Left ventricular systolic dysfunction increases the risk of atrial and VAs like in other disease states. • Eliciting the overall goals of care and preferences led to the patient's decision to move ahead with primary prevention ICD. • Patients with NMDs can have protracted admissions at CIED placement due to underlying skeletal muscle dysfunction including respiratory involvement. Therapy to return patients to preimplant level of functioning is necessary. • Progressive noncardiac issues typically limit the quality and duration of life.

Articles in this issue

Archives of this issue

view archives of HRS Guidelines Bundle (free trial) - Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders